Aerovate Therapeutics
AVTE
#9233
Rank
$73.33 M
Marketcap
$2.53
Share price
0.40%
Change (1 day)
-90.45%
Change (1 year)

Aerovate Therapeutics (AVTE) - Cash on Hand

Cash on Hand as of December 2024 : $78.62 Million USD

According to Aerovate Therapeutics's latest financial reports the company has $78.62 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Aerovate Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.12 B-5.25%
2022-12-31$0.12 B-22.8%
2021-12-31$0.16 B3560.07%
2020-12-31$4.57 M30.14%
2019-12-31$3.51 M